How robotics and gene therapies are shaping retina research, now and in the days to come
Evidence from clinical trials and real-world situations demonstrates the effectiveness and convenience of intraocular drugs to control postoperative inflammation.
Recent reports of retinal atrophy have raised concerns on potential long-term safety.
Gene therapy for nAMD represents significant advancements in the treatment of retinal conditions
COVID-19 has had a significant impact on the entire global community. As we look to the future to advance the provision of eyecare excellence, opportunities for innovation must be embraced and new, patient-centric ways of managing clinical practices adopted.
This article is produced by iCare Finland for healthcare professionals and is not intended to provide medical advice and/or treatment guidance. This website is not country-specific and therefore may contain information which is not applicable to your country.
Laser surgery is an appropriate adjunctive therapy across the continuum of glaucoma care, as well as a safe option for patients who also have cataracts and other complicating factors
Novel procedures may hold greater appeal for cataract and refractive surgeons
Methods using a combination of non-invasive thermal treatments and meibomian gland expression seem to be particularly effective.
At the Retina World Congress, we spoke with Siegfried Priglinger, MD, about ensuring the best outcomes for preschool-aged patients
Patients appreciate the convenience and aesthetic improvements of light-based dry eye treatment, and it can also be applied elsewhere on the face.
Insights from a genome-wide association study identify novel genetic loci
Children with certain neurodevelopmental disorders show altered ocular movements and a more reduced amplitude of accommodation, however, vision problems are not always present in these children and so cannot be considered an aetiological factor.
A different approach better serves patients with diabetic retinopathy
The healthcare sector has high greenhouse gas emissions, to which ophthalmology is a significant contributor. Reducing waste, reusing instruments and medication and increasing our use of telemedicine can all contribute to reducing the carbon footprint of our specialty.
Dr Wykoff addressed the top three questions retina specialists have about retinal non-perfusion
Innovative new features build on the benefits of the iCare COMPASS Automated Perimeter
Promising innovations are not one-size-fits-all
A corneal refractive technique can combine monovision and extended depth of field to create a wide, seamless range of functional vision. This can provide independence from spectacles.
Dr Arun C. Gulani explains how his corneal surface technique offers a contrast to cutting procedures without risk, pain or drama.
Research findings from the multicentre clinical study were presented at the European Society of Ophthalmology (SOE) meeting in Lisbon, Portugal
An interdisciplinary team at Duke University has developed a proof-of-concept machine learning model capable of detecting symptomatic Alzheimer disease using multimodal retinal imaging data.
Recent reports of retinal atrophy have raised concerns on potential long-term safety.
Prompt, careful use of laser-based treatment minimises postoperative adverse effects.
Advancements in lens technology reflect the growing popularity of multifocal lenses
Dr Jayanth Sridhar shares a day in the life of an academic retina specialist.
With at least 24 inherited retinal disease (IRD) clinical trials ongoing in the United States, and additional studies of stem cell therapy in several IRD indications, hope is on the horizon for many patients.